» Authors » S M van Rooden

S M van Rooden

Explore the profile of S M van Rooden including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 311
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Verberk J, Aghdassi S, Abbas M, Naucler P, Gubbels S, Maldonado N, et al.
J Hosp Infect . 2022 Jan; 122:35-43. PMID: 35031393
Background: As most automated surveillance (AS) methods to detect healthcare-associated infections (HAIs) have been developed and implemented in research settings, information about the feasibility of large-scale implementation is scarce. Aim:...
2.
van Rooden S, Verbaan D, Stijnen T, Marinus J, van Hilten J
Parkinsonism Relat Disord . 2016 Jan; 24:113-8. PMID: 26774535
Introduction: The influence of approaching death in addition to age and their interaction on the course of a broad spectrum of nondopaminergic features in Parkinson's disease (PD) has not been...
3.
Verbaan D, van Rooden S, Benit C, van Zwet E, Marinus J, van Hilten J
Parkinsonism Relat Disord . 2011 Jun; 17(8):632-4. PMID: 21696993
Background: Motor impairment in Parkinson's disease (PD) can be evaluated with the Short Parkinson's Evaluation Scale/Scales for Outcomes in Parkinson's disease (SPES/SCOPA) and the Movement Disorder Society-Unified Parkinson's Disease Rating...
4.
van Rooden S, Visser M, Verbaan D, Marinus J, van Hilten J
J Neurol Neurosurg Psychiatry . 2009 Feb; 80(8):846-50. PMID: 19211596
Objective: To evaluate the presence and nature of patterns of coherency among the motor and non-motor domains in Parkinson's disease (PD) and to examine which clinical parameters are related to...
5.
van Rooden S, Visser M, Verbaan D, Marinus J
Parkinsonism Relat Disord . 2008 Dec; 15(7):546-7. PMID: 19073372
No abstract available.
6.
Verbaan D, Boesveldt S, van Rooden S, Visser M, Marinus J, Macedo M, et al.
Neurology . 2008 Dec; 71(23):1877-82. PMID: 19047559
Objective: To evaluate the relation between olfactory impairment (OI) and other impairment domains in Parkinson disease (PD) and the characteristics of OI in patients with certain genotypic characteristics. Methods: In...
7.
Visser M, van Rooden S, Verbaan D, Marinus J, Stiggelbout A, van Hilten J
J Neurol . 2008 Sep; 255(10):1580-7. PMID: 18821041
Background: Insight in how impairments and disabilities related to Parkinson's disease (PD) influence health-related quality of life (HRQoL) is required to review adequacy of current management strategies. Methods: The Scales...
8.
Verbaan D, Marinus J, Visser M, van Rooden S, Stiggelbout A, van Hilten J
Neurology . 2007 Jul; 69(4):333-41. PMID: 17646625
Objective: There is a wide range of autonomic symptoms (AS) in Parkinson disease (PD), but the full spectrum has never been evaluated with a validated instrument and in comparison with...
9.
Verbaan D, Marinus J, Visser M, van Rooden S, Stiggelbout A, Middelkoop H, et al.
J Neurol Neurosurg Psychiatry . 2007 Apr; 78(11):1182-7. PMID: 17442759
Background: Cognitive impairment plays a role in Parkinson's disease (PD) and has important consequences for patient management. However, many aspects of cognitive impairment in PD remain unclear because of the...